New Zealand markets closed

Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
8.33-0.26 (-3.03%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 1.97B
Enterprise value 2.54B
Trailing P/E 29.54
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.29
Price/book (mrq)1.94
Enterprise value/revenue 2.76
Enterprise value/EBITDA 26.35

Trading information

Stock price history

Beta (5Y monthly) -0.16
52-week change 3-36.04%
S&P500 52-week change 324.60%
52-week high 314.33
52-week low 37.59
50-day moving average 310.42
200-day moving average 311.50

Share statistics

Avg vol (3-month) 33.53M
Avg vol (10-day) 33.22M
Shares outstanding 5229.41M
Implied shares outstanding 6229.41M
Float 8120.46M
% held by insiders 142.41%
% held by institutions 19.11%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.07
Forward annual dividend yield 40.81%
Trailing annual dividend rate 30.07
Trailing annual dividend yield 30.81%
5-year average dividend yield 4N/A
Payout ratio 434.39%
Dividend date 3N/A
Ex-dividend date 425 Jun 2024
Last split factor 21.4:1
Last split date 328 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.73%
Operating margin (ttm)11.82%

Management effectiveness

Return on assets (ttm)2.82%
Return on equity (ttm)6.57%

Income statement

Revenue (ttm)922.55M
Revenue per share (ttm)3.98
Quarterly revenue growth (yoy)-15.10%
Gross profit (ttm)N/A
EBITDA 103.83M
Net income avi to common (ttm)71.35M
Diluted EPS (ttm)0.29
Quarterly earnings growth (yoy)-37.90%

Balance sheet

Total cash (mrq)140.72M
Total cash per share (mrq)0.64
Total debt (mrq)713.48M
Total debt/equity (mrq)70.26%
Current ratio (mrq)0.97
Book value per share (mrq)4.64

Cash flow statement

Operating cash flow (ttm)98.7M
Levered free cash flow (ttm)13.1M